Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imatinib in Adult Patients With Metastatic Ocular Melanoma (O-Mel-Inib)

This study has been terminated.
(Study stopped at the end of the first step)
National Cancer Institute, France
Information provided by (Responsible Party):
Centre Oscar Lambret Identifier:
First received: January 9, 2007
Last updated: January 5, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)